1. Home
  2. Analysis
  3. Magnesium-glycinate
  4. Montelukast-sodium

Magnesium glycinate and Montelukast sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 8 people who take Magnesium glycinate and Montelukast sodium. Common interactions include dyspnoea among females.

The phase IV clinical study analyzes what interactions people who take Magnesium glycinate and Montelukast sodium have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

What are phase IV trials?

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 24, 2023

8 people who take Magnesium glycinate and Montelukast sodium together, and have interactions are studied.

What is Magnesium glycinate?

Magnesium glycinate has active ingredients of magnesium. It is used in insomnia. Currently, eHealthMe is studying from 930 Magnesium glycinate users.

What is Montelukast sodium?

Montelukast sodium has active ingredients of montelukast sodium. It is used in asthma. Currently, eHealthMe is studying from 22,721 Montelukast sodium users.

Number of Magnesium glycinate and Montelukast sodium reports submitted per year:

Magnesium glycinate and Montelukast sodium drug interactions.

Common Magnesium Glycinate and Montelukast Sodium drug interactions by gender *:

female:

  1. Dyspnoea
  2. Rash
  3. Fatigue
  4. Gastrooesophageal reflux disease
  5. Hyperhidrosis
  6. Malaise
  7. Muscle fatigue
  8. Muscle spasms
  9. Muscle strain
  10. Nausea

male:

n/a

Common Magnesium Glycinate and Montelukast Sodium drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cough
  2. Dry skin
  3. Dyspnoea
  4. Injection site dryness
  5. Middle insomnia
  6. Pruritus
  7. Rash
  8. Sinus congestion

50-59:

  1. Abdominal discomfort
  2. Anxiety
  3. Arthralgia
  4. Asthenia
  5. Blood creatinine increased
  6. Chills
  7. Constipation
  8. Dizziness
  9. Dyspnoea
  10. Fatigue

60+:

  1. Cardiomyopathy
  2. Contusion
  3. Drug ineffective
  4. Haemoglobin decreased
  5. Impaired healing
  6. Pericardial effusion
  7. Small intestinal haemorrhage
  8. Uterine pain
  9. Vulvovaginal dryness
  10. Weight decreased

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium glycinate and Montelukast sodium?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Montelukast sodium side effects:

Browse all side effects of Montelukast sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Magnesium glycinate interactions:

Browse all interactions between Magnesium glycinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Montelukast sodium interactions:

Browse all interactions between Montelukast sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on magnesium and montelukast sodium (the active ingredients of Magnesium glycinate and Montelukast sodium, respectively), and Magnesium glycinate and Montelukast sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Magnesium glycinate and Montelukast sodium.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.